Prior Authorization Requirements and Medicaid Enrollees' Use of Tobacco Cessation Medications, Colorado, 2023.

Autor: Dillender M; Marcus Dillender is with the Department of Economics, Vanderbilt University, Nashville, TN. Robin Mermelstein is with the Department of Psychology and the Institute for Health Research and Policy, University of Illinois at Chicago., Mermelstein R; Marcus Dillender is with the Department of Economics, Vanderbilt University, Nashville, TN. Robin Mermelstein is with the Department of Psychology and the Institute for Health Research and Policy, University of Illinois at Chicago.
Jazyk: angličtina
Zdroj: American journal of public health [Am J Public Health] 2025 Jan; Vol. 115 (1), pp. 42-46. Date of Electronic Publication: 2024 Oct 24.
DOI: 10.2105/AJPH.2024.307868
Abstrakt: Despite tobacco cessation medications being a first-line treatment for quitting smoking, a majority of Medicaid programs require health care providers to obtain prior authorization before prescribing them. We examined the impact of Colorado's Medicaid program removing its prior authorization requirement for these drugs on their use and estimated the additional number of Coloradoans who used these therapies in 2023 because of the policy change. The findings indicate that these requirements decrease low-income people's use of these medications. ( Am J Public Health . 2025;115(1):42-46. https://doi.org/10.2105/AJPH.2024.307868).
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje